Author:
Khosla Divya,Singla Aditya Kumar,Gupta Rahul,Kapoor Rakesh
Publisher
Springer Nature Singapore
Reference131 articles.
1. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ (2020) Trends in incidence of early-onset colorectal cancer in the united states among those approaching screening age. JAMA Netw Open 3(1):e1920407
2. Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C et al (2011) Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol 18(9):2461–2468
3. Ahmed FE, Amed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Allison RR (2012) Diagnostic microRNA markers to screen for sporadic human colon cancer in blood. Cancer Genomics Proteomics 9(4):179–192
4. Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ et al (2008) Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26(10):1626–1634
5. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS et al (2019) Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol 4(7):511–518